Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection

Nature Protocols

Volumn 9, Issue 3, 2014, Pages 541-558

  Volpi, Nicola ^a   Galeotti, Fabio ^a   Yang, Bo ^b   Linhardt, Robert J ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOACRIDONE; ACID GLYCOSAMINOGLYCAN; CHONDROITIN; DISACCHARIDE; REDUCING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOHYDRATE ANALYSIS; DEPOLYMERIZATION; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION;

AMINOACRIDINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISACCHARIDES; FLUORESCENCE; GLYCOSAMINOGLYCANS; MASS SPECTROMETRY; STAINING AND LABELING;

EID: 84895505637     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2014.026     Document Type: Article

References (112)

1. Gupta, G. & Surolia, A. Glycomics: An overview of the complex glycocode. Adv. Exp. Med. Biol. 749, 1-13 (2012
2. Raman, R. et al. Glycomics: An integrated systems approach to structure-function relationships of glycans. Nat. Methods 2, 817-824 (2005
3. Shriver, Z. et al. Glycomics: A pathway to a class of new and improved therapeutics. Nat. Rev. Drug Discov. 3, 863-873 (2004
4. Dennis, J.W. et al. Protein glycosylation in development and disease. Bioessays 21, 412-421 (1999
5. Feizi, T. & Mulloy, B. Carbohydrates and glycoconjugates. Glycomics: The new era of carbohydrate biology. Curr. Opin. Struct. Biol. 13, 602-604 (2003
6. Ly, M. et al. Proteoglycanomics: Recent progress and future challenges. OMICS 14, 389-399 (2010
7. Gesslbauer, B. et al. Proteoglycanomics: Tools to unravel the biological function of glycosaminoglycans. Proteomics 7, 2870-2880 (2007
8. Morgan, M.R. et al. Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 8, 957-969 (2007
9. Capila, I. & Linhardt, R.J. Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41, 391-412 (2002
10. Cattaruzza, S. & Perris, R. Approaching the proteoglycome: Molecular interactions of proteoglycans and their functional output. Macromol. Biosci. 6, 667-680 (2006
11. Cattaruzza, S. et al. Proteoglycans in the control of tumor growth and metastasis formation. Connect. Tissue Res. 49, 225-229 (2008
12. Gesslbauer, B. et al. New targets for glycosaminoglycans and glycosaminoglycans as novel targets. Exp. Rev. Proteomics 10, 77-95 (2013
13. Zhao, X. et al. Sequence analysis and domain motifs in the porcine skin decorin glycosaminoglycan chain. J. Biol. Chem. 288, 9226-9237 (2013
14. Li, L. et al. Proteoglycan sequence. Mol. Biosyst. 8, 1613-1625 (2012
15. Jackson, R.L. et al. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71, 481-539 (1991
16. Gama, C.I. & Hsieh-Wilson, L.C. Chemical approaches to deciphering the glycosaminoglycan code. Curr. Opin. Chem. Biol. 9, 609-619 (2005
17. Fraser, J.R.E. et al. Hyaluronan: Its nature, distribution, functions and turnover. J. Intern. Med. 242, 27-33 (1997
18. Volpi, N. Analytical aspects of pharmaceutical grade chondroitin sulfates. J. Pharm. Sci. 96, 3168-3180 (2007
19. Sugahara, K. et al. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 13, 612-620 (2003
20. Yamada, S. & Sugahara, K. Potential therapeutic application of chondroitin sulfate/dermatan sulfate. Curr. Drug. Discov. Technol. 5, 289-301 (2008
21. Sugahara, K. & Mikami, T. Chondroitin/dermatan sulfate in the central nervous system. Curr. Opin. Struct. Biol. 17, 536-545 (2007
22. Volpi, N. Advances in chondroitin sulfate analysis: Application in physiological and pathological states of connective tissue and during pharmacological treatment of osteoarthritis. Curr. Pharm. Des. 12, 639-658 (2006
23. Linhardt, R.J. et al. New methodologies in heparin structure analysis and the generation of LMW heparins. Adv. Exp. Med. Biol. 313, 37-47 (1992
24. Rabenstein, D.L. Heparin and heparan sulfate: Structure and function. Nat. Prod. Rep. 19, 312-331 (2002
25. Casu, B. Structure of heparin and heparin fragments. Ann. N.Y. Acad. Sci. 556, 1-17 (1989
26. Casu, B. Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 43, 51-134 (1985
27. Kamhi, E. et al. Glycosaminoglycans in infectious disease. Biol. Rev. Camb. Philos. Soc. 88, 928-943 (2013
28. Kogan, G. et al. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett. 29, 17-25 (2007
29. Volpi, N. et al. Role, metabolism, chemical modifications and applications of hyaluronan. Curr. Med. Chem. 16, 1718-1745 (2009
30. Gray, E. et al. The anticoagulant and antithrombotic mechanisms of heparin. Handb. Exp. Pharmacol. 207, 43-61 (2012
31. Hassan, Y. et al. Heparin-induced thrombocytopenia and recent advances in its therapy. J. Clin. Pharm. Ther. 32, 535-544 (2007
32. Masuko, S. & Linhardt, R.J. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics. Future Med. Chem. 4, 289-296 (2012
33. Wang, Z et al. Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl. Microbiol. Biotechnol. 91, 91-99 (2011
34. Zhou, H. et al. M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS ONE 6, e21106 (82011
35. Volpi, N. (Ed.) Chondroitin Sulfate: Structure, Role, and Pharmacological Activity (Academic Press, 2006
36. Karst, N.A. & Linhardt, R.J. Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides. Curr. Med. Chem. 10, 1993-2031 (2003
37. Leymarie, N. & Zaia, J. Effective use of mass spectrometry for glycan and glycopeptide structural analysis. Anal. Chem. 84, 3040-3048 (2012
38. Volpi, N. et al. Electrophoresis for the analysis of heparin purity and quality. Electrophoresis 33, 1531-1537 (2012
39. Yang, B. et al. Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal. Bioanal. Chem. 399, 541-557 (2011
40. Sisu, E. et al. Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans. Amino Acids 41, 235-256 (2011
41. Beni, S. et al. Analysis and characterization of heparin impurities. Anal. Bioanal. Chem. 399, 527-239 (2011
42. Zaia, J. Mass spectrometry and glycomics. OMICS 14, 401-418 (2010
43. Zaia, J. On-line separations combined with MS for analysis of glycosaminoglycans. Mass. Spectrom. Rev. 28, 254-272 (2009
44. Volpi, N. et al. Capillary electrophoresis of complex natural polysaccharides. Electrophoresis 29, 3095-3106 (2008
45. Amon, S. et al. Glycosylation analysis of glycoproteins and proteoglycans using capillary electrophoresis-mass spectrometry strategies. Electrophoresis 29, 2485-2507 (2008
46. Volpi, N. & Linhardt, R.J. High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan- derived oligosaccharides. Nat. Protoc. 5, 993-1004 (2010
47. Michaud, P. et al. Polysaccharide lyases: Recent developments as biotechnological tools. Crit. Rev. Biotechnol. 23, 233-266 (2003
48. Ernst, S. et al. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30, 387-444 (1995
49. Linhardt, R.J. et al. Polysaccharide lyases. Appl. Biochem. Biotechnol. 12, 135-176 (1986
50. Xia, B. et al. Versatile fluorescent derivatization of glycans for glycomic analysis. Nat. Methods 2, 845-850 (2005
51. Hase, H. Precolumn derivatization for chromatographic and electrophoretic analyses of carbohydrates. J. Chrom. A 720, 173-182 (1996
52. Chang, Y. et al. Capillary electrophoresis for the analysis of glycosaminoglycan-derived disaccharides. Methods Mol. Biol. 984, 67-77 (2013
53. Chang, Y. et al. Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection. Anal. Biochem. 427, 91-98 (2012
54. Yang, B. et al. Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry. J. Chromatogr. A 1225, 91-98 (2012
55. Galeotti, F. & Volpi, N. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-Aminoacridone. Anal. Chem. 83, 6770-6777 (2011
56. Takegawa, Y. et al. Simultaneous analysis of heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan disaccharides by glycoblotting-Assisted sample preparation followed by single-step zwitterionic-hydrophilic interaction chromatography. Anal. Chem. 83, 9443-9449 (2011
57. Skidmore, M.A. et al. Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection. Nat. Protoc. 5, 1983-1992 (2010
58. Volpi, N. High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyaluronan disaccharides derivatized with 2-Aminoacridone. Anal. Biochem. 397, 12-23 (2010
59. Ambrosius, M. et al. Quantitative determination of the glycosaminoglycan δ-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 1201, 54-60 (2008
60. Deakin, J.A. et al. Simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology 18, 483-491 (2008
61. Hitchcock, A.M. et al. Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection. Electrophoresis 29, 4538-4548 (2008
62. Militsopoulou, M. et al. Determination of twelve heparin-And heparan sulfate-derived disaccharides as 2-Aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser-induced fluorescence detection. Electrophoresis 23, 1104-1109 (2002
63. Okafo, G. et al. A coordinated high-performance liquid chromatographic, capillary electrophoretic, and mass spectrometric approach for the analysis of oligosaccharide mixtures derivatized with 2-Aminoacridone. Anal. Chem. 68, 4424-4430 (1996
64. Starr, C.M. et al. Fluorophore-Assisted carbohydrate electrophoresis in the separation, analysis, and sequencing of carbohydrates. J. Chromatogr. A 720, 295-321 (1996
65. Imanari, T. et al. High-performance liquid chromatographic analysis of glycosaminoglycan-derived oligosaccharides. J. Chromatogr. A 720, 275-293 (1996
66. Galeotti, F. & Volpi, N. Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides. J. Chromatogr. A 1284, 141-147 (2013
67. Karamanos, N.K. et al. Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. J. Chromatogr. A 765, 169-179 (1997
68. Calabro, A. et al. Fluorophore-Assisted carbohydrate electrophoresis (FACE) of glycosaminoglycans. Osteoarthritis Cartilage 9, S16-S22 (2001
69. Okafo, G. et al. A coordinated high-performance liquid chromatographic, capillary electrophoretic, and mass spectrometric approach for the analysis of oligosaccharide mixtures derivatized with 2-Aminoacridone. Anal. Chem. 68, 4424-4430 (1996
70. Zhang, Z. et al. Liquid chromatography-mass spectrometry to study chondroitin lyase action pattern. Anal. Biochem. 385, 57-64 (2009
71. Linhardt, R.J. Analysis of glycosaminoglycans with polysaccharide lyases. Curr. Protoc. Mol. Biol. 48, 17.13.B.1-17.13.B.16 (2001
72. Buzzega, D. et al. Fluorophore-Assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low-molecular-weight (LMW) heparins. Electrophoresis 29, 4192-4202 (2008
73. Volpi, N. & Maccari, F. Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains-All. Electrophoresis 23, 4060-4066 (2002
74. Zhang, F. et al. Microscale isolation and analysis of heparin from plasma using an anion exchange column. Anal. Biochem. 353, 284-286 (2006
75. Shao, C. et al. Comparative glycomics of leukocyte glycosaminoglycans. FEBS J. 280, 2447-2461 (2013
76. Di Iorio, E. et al. Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea. Exp. Eye Res. 91, 293-299 (2010
77. Mizumoto, S. & Sugahara, K. Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization). Methods Mol. Biol. 836, 99-115 (2012
78. Cesaretti, M. et al. A 96-well assay for uronic acid carbazole reaction. Carb. Polym. 54, 59-61 (2003
79. Malavaki, C.J. et al. Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations. Anal. Biochem. 374, 213-220 (2008
80. Korir, A.K. et al. Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate. Anal. Chem. 80, 1297-1306 (2008
81. Saad, O.M. & Leary, J.A. Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal. Chem. 75, 2985-2995 (2003
82. Zhang, Z. et al. Tandem MS can distinguish hyaluronic acid from N-Acetylheparosan. J. Am. Soc. Mass Spectrom. 19, 82-90 (2008
83. Kailemia, M.J. et al. Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. Anal. Chem. 84, 5475-5478 (2012
84. Galeotti, F. et al. On-line high-performance liquid chromatography- fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-Aminoacridone. Anal. Biochem. 430, 97-104 (2012
85. Lawrence, R. et al. Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat. Methods 5, 291-292 (2008
86. Da Col, R. et al. Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interface. J. Chromatogr. 647, 289-300 (1993
87. Oguma, T. et al. Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: Application to analyses of the tumor tissue sections on glass slides. Biomed. Chromatogr. 15, 356-362 (2001
88. Oguma, T. et al. Analytical method of heparan sulfates using high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 754, 153-159 (2001
89. Zaia, J. & Costello, C.E. Compositional analysis of glycosaminoglycans by electrospray mass spectrometry. Anal. Chem. 73, 233-239 (2001
90. Hitchcock, A.M. et al. Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-Tandem mass spectrometry platform. Biochemistry 45, 2350-2361 (2006
91. Kuberan, B. et al. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography- microelectrospray ionization time-of-flight mass spectrometry. J. Am. Chem. Soc. 124, 8707-8718 (2002
92. Kühn, A.V. et al. Quantification of hyaluronic acid fragments in pharmaceutical formulations using LC-ESI-MS. J. Pharm. Biomed. Anal. 30, 1531-1537 (2003
93. Thanawiroon, C. et al. Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J. Biol. Chem. 279, 2608-2615 (2004
94. Volpi, N. Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers. Rapid Commun. Mass Spectrom. 21, 3459-3466 (2007
95. Volpi, N. et al. Mass spectrometry for the characterization of unsulfated chondroitin oligosaccharides from 2-mers to 16-mers. Comparison with hyaluronic acid oligomers. Rapid Commun. Mass Spectrom. 22, 3526-3530 (2008
96. Volpi, N. Chondroitin C lyase [4.2.2.] is unable to cleave fructosylated sequences inside the partially fructosylated Escherichia coli K4 polymer. Glycoconj. J. 25, 451-457 (2008
97. Volpi, N. & Maccari, F. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis. Glycobiology 19, 356-367 (2009
98. Henriksen, J. et al. On-line size-exclusion chromatography/mass spectrometry of low-molecular-mass heparin. J. Mass Spectrom. 39, 1305-1312 (2004
99. Barroso, B. et al. Analysis of proteoglycans derived sulphated disaccharides by liquid chromatography/mass spectrometry. J. Chromatogr. A 1080, 43-48 (2005
100. Karlsson, N.G. et al. Use of graphitised carbon negative ion LC-MS to analyse enzymatically digested glycosaminoglycans. J. Chromatogr. B 824, 139-147 (2005
101. Henriksen, J. et al. Ion-pairing reversed-phased chromatography/mass spectrometry of heparin. Carb. Res. 341, 382-387 (2006
102. Bisio, A. et al. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase. Semin. Throm. Hemost. 33, 488-495 (2007
103. Volpi, N. On-line HPLC/ESI-MS separation and characterization of hyaluronan oligosaccharides from 2-mers to 40-mers. Anal. Chem. 79, 6390-6397 (2007
104. Naimy, H. et al. Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry. Biochemistry 47, 3155-3161 (2008
105. Hitchcock, A.M. et al. Comparative glycomics of connective tissue glycosaminoglycans. Proteomics 8, 1384-1397 (2008
106. Doneanu, C.E. et al. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry. Anal. Chem. 81, 3485-3499 (2009
107. Zhang, Z. et al. Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry. Anal. Chem. 81, 4349-4355 (2009
108. Heinegard, D. Hyaluronidase digestion and alkaline treatment of bovine tracheal cartilage proteoglycans. Biochem. Biophys. Acta 285, 193-207 (1972
109. Brustkern, A.M. et al. Characterization of currently marketed heparin products: Reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests. Anal. Chem. 82, 9865-9870 (2012
110. Yang, B. et al. Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal. Biochem. 415, 59-66 (2011
111. Wang, B. et al. Characterization of currently marketed heparin products: Analysis of heparin digests by RPIP-UHPLC-QTOF-MS. J. Pharm. Biomed. Anal. 67-68, 42-50 (2012
112. Li, L. et al. Top-down approach for the direct characterization of low-molecular-weight heparins using LC-FT-MS. Anal. Chem. 84, 8822-8829 (2013